Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

Jacobs ET, Giuliano AR, Martínez ME, Hollis BW, Reid ME, Marshall JR.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):533-7.

PMID:
15225833
2.

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):121-6.

3.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.

Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7.

4.

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52.

5.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

PMID:
17623801
6.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.

Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1059-65.

7.

Vitamin D and intervention trials in prostate cancer: from theory to therapy.

Schwartz GG.

Ann Epidemiol. 2009 Feb;19(2):96-102. doi: 10.1016/j.annepidem.2008.03.007. Epub 2008 Jul 10. Review.

PMID:
18619854
8.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

9.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720
10.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.

11.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

12.

The role of vitamin D in prostate cancer.

Zhao XY, Feldman D.

Steroids. 2001 Mar-May;66(3-5):293-300. Review.

PMID:
11179737
13.

Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D.

Cancer Causes Control. 1997 Jul;8(4):615-25.

PMID:
9242478
14.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

PMID:
17974532
15.

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

Giovannucci E.

Cancer Causes Control. 2005 Mar;16(2):83-95. Review.

PMID:
15868450
16.

The roles of cytochrome P450 enzymes in prostate cancer development and treatment.

Chen TC, Sakaki T, Yamamoto K, Kittaka A.

Anticancer Res. 2012 Jan;32(1):291-8. Review.

PMID:
22213318
17.

Vitamin D and prevention of colorectal adenoma: a meta-analysis.

Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2958-69. doi: 10.1158/1055-9965.EPI-08-0402.

18.

Vitamin D and the epidemiology of prostate cancer.

Schwartz GG.

Semin Dial. 2005 Jul-Aug;18(4):276-89. Review.

PMID:
16076349
19.

Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Trial Project Team.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2623-30.

20.

1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.

Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T.

Carcinogenesis. 2005 Feb;26(2):429-40. Epub 2004 Nov 11.

PMID:
15539405

Supplemental Content

Support Center